Literature DB >> 32561899

Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.

José Marcos Moreno-Cabrera1,2,3, Jesús Del Valle2,3, Elisabeth Castellanos1, Lidia Feliubadaló2,3, Marta Pineda2,3, Joan Brunet2,3,4, Eduard Serra1,3, Gabriel Capellà2,3, Conxi Lázaro5,6, Bernat Gel7.   

Abstract

Although germline copy-number variants (CNVs) are the genetic cause of multiple hereditary diseases, detecting them from targeted next-generation sequencing data (NGS) remains a challenge. Existing tools perform well for large CNVs but struggle with single and multi-exon alterations. The aim of this work is to evaluate CNV calling tools working on gene panel NGS data and their suitability as a screening step before orthogonal confirmation in genetic diagnostics strategies. Five tools (DECoN, CoNVaDING, panelcn.MOPS, ExomeDepth, and CODEX2) were tested against four genetic diagnostics datasets (two in-house and two external) for a total of 495 samples with 231 single and multi-exon validated CNVs. The evaluation was performed using the default and sensitivity-optimized parameters. Results showed that most tools were highly sensitive and specific, but the performance was dataset dependant. When evaluating them in our diagnostics scenario, DECoN and panelcn.MOPS detected all CNVs with the exception of one mosaic CNV missed by DECoN. However, DECoN outperformed panelcn.MOPS specificity achieving values greater than 0.90 when using the optimized parameters. In our in-house datasets, DECoN and panelcn.MOPS showed the highest performance for CNV screening before orthogonal confirmation. Benchmarking and optimization code is freely available at https://github.com/TranslationalBioinformaticsIGTP/CNVbenchmarkeR .

Entities:  

Year:  2020        PMID: 32561899      PMCID: PMC7784926          DOI: 10.1038/s41431-020-0675-z

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.

Authors:  Serena Corsini; Elena Pedrini; Claudio Patavino; Maria Gnoli; Marcella Lanza; Luca Sangiorgi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

Review 2.  Prenatal Exome Sequencing: Background, Current Practice and Future Perspectives-A Systematic Review.

Authors:  Daniele Guadagnolo; Gioia Mastromoro; Francesca Di Palma; Antonio Pizzuti; Enrica Marchionni
Journal:  Diagnostics (Basel)       Date:  2021-02-02

3.  BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort.

Authors:  Paula Rofes; Jesús Del Valle; Sara Torres-Esquius; Lídia Feliubadaló; Agostina Stradella; José Marcos Moreno-Cabrera; Adriana López-Doriga; Elisabet Munté; Rafael De Cid; Olga Campos; Raquel Cuesta; Álex Teulé; Èlia Grau; Judit Sanz; Gabriel Capellá; Orland Díez; Joan Brunet; Judith Balmaña; Conxi Lázaro
Journal:  Genes (Basel)       Date:  2021-01-23       Impact factor: 4.096

4.  Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.

Authors:  Louisa Lepkes; Mohamad Kayali; Britta Blümcke; Jonas Weber; Malwina Suszynska; Sandra Schmidt; Julika Borde; Katarzyna Klonowska; Barbara Wappenschmidt; Jan Hauke; Piotr Kozlowski; Rita K Schmutzler; Eric Hahnen; Corinna Ernst
Journal:  Cancers (Basel)       Date:  2021-01-01       Impact factor: 6.639

5.  Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.

Authors:  Yoshie Yoshikawa; Yusuke Yamada; Mitsuru Emi; Lilit Atanesyan; Jan Smout; Karel de Groot; Suvi Savola; Yukako Nakanishi-Shinkai; Akihiro Kanematsu; Michio Nojima; Masaki Ohmuraya; Tomoko Hashimoto-Tamaoki; Shingo Yamamoto
Journal:  Cancer Sci       Date:  2021-11-03       Impact factor: 6.716

6.  Family with congenital contractural arachnodactyly due to a novel multiexon deletion of the FBN2 gene.

Authors:  Hiroki Yagi; Hiroshi Takiguchi; Norifumi Takeda; Ryo Inuzuka; Yuki Taniguchi; Kristine Joyce Porto; Hiroyuki Ishiura; Jun Mitsui; Hiroyuki Morita; Issei Komuro
Journal:  Clin Case Rep       Date:  2022-02-09

7.  Detecting copy number variation in next generation sequencing data from diagnostic gene panels.

Authors:  Ashish Kumar Singh; Maren Fridtjofsen Olsen; Liss Anne Solberg Lavik; Trine Vold; Finn Drabløs; Wenche Sjursen
Journal:  BMC Med Genomics       Date:  2021-08-31       Impact factor: 3.063

Review 8.  Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies.

Authors:  Álvaro Beltrán-Corbellini; Ángel Aledo-Serrano; Rikke S Møller; Eduardo Pérez-Palma; Irene García-Morales; Rafael Toledano; Antonio Gil-Nagel
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

Review 9.  A Simple Practical Guide to Genomic Diagnostics in a Pediatric Setting.

Authors:  Alan Taylor; Zeinab Alloub; Ahmad Abou Tayoun
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

10.  VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage.

Authors:  Francesco Musacchia; Marianthi Karali; Annalaura Torella; Steve Laurie; Valeria Policastro; Mariateresa Pizzo; Sergi Beltran; Giorgio Casari; Vincenzo Nigro; Sandro Banfi
Journal:  Genes (Basel)       Date:  2021-12-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.